Update for Labs
Hey everyone, welcome back to the weekly check-in. So, recently I’ve been struggling to get into the lab, due to not being a University of Arizona student, but I am starting to develop my final product and presentation for the research. Throughout this, I plan on focusing on the process of what immunotherapy is and how it works in the body.
Additionally, it was also suggested for me to talk about some things that I have been able to use and observe throughout my research. The one that I use the most is the monoclonal antibody, a protein we created in the lab to specifically identify cancer antibodies. The mAbs (monoclonal antibodies) blockade the inhibitory pathways or push the T cells close to the cancer sites to reduce the cancer sites. In CAR-T Therapy, however, induce the immune response against cancer antigens via T-cell generation.
These contrasting methods are usually tested against each other to determine which method is more effective depending on the type of cancer. Right now, we are currently testing their efficiency on colorectal cancer (CRC) and I will update you soon on the progress of that soon.
See you all next week!